Quirk Gerald E
Insider CIK 1479603 · INFI See Remarks · TKAI General Counsel, Executive VP · SYRS Chief Legal Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2024-11-19 | 2024-11-20 | 46,657 | $0.22 | $10.3K | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2024-09-30 | 2024-10-02 | 10,000 | — | $0 | 20,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | F Tax w/h | 2024-09-30 | 2024-10-02 | 3,100 | $2.10 | $6.5K | 46,657 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise | 2024-09-30 | 2024-10-02 | 10,000 | — | $0 | 49,757 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | F Tax w/h | 2024-03-28 | 2024-04-02 | 7,046 | $5.59 | $39.4K | 39,757 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2024-03-27 | 2024-04-02 | 22,500 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise | 2024-03-27 | 2024-04-02 | 22,500 | — | $0 | 46,803 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | F Tax w/h | 2023-10-19 | 2023-10-20 | 6,897 | $2.10 | $14.5K | 24,303 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2023-10-11 | 2023-10-20 | 22,500 | — | $0 | 22,500 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise | 2023-10-11 | 2023-10-20 | 22,500 | — | $0 | 31,200 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2023-09-12 | 2023-09-14 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-10-11 | 2022-10-13 | 45,000 | — | $0 | 45,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2021-02-17 | 2021-02-19 | 94,000 | — | $0 | 94,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2020-02-13 | 2020-02-14 | 94,000 | — | $0 | 94,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2019-02-12 | 2019-02-14 | 75,000 | — | $0 | 75,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award | 2019-02-12 | 2019-02-14 | 87,000 | — | $0 | 87,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2018-02-16 | 2018-02-21 | 11,666 | — | $0 | 11,666 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2018-02-16 | 2018-02-21 | 75,000 | — | $0 | 75,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2017-02-10 | 2017-02-13 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2016-09-27 | 2020-12-21 | 35,000 | — | $0 | 35,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2016-09-27 | 2016-09-29 | 105,000 | — | $0 | 105,000 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | A Award deriv | 2015-12-15 | 2015-12-17 | 62,000 | — | $0 | 62,000 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | A Award deriv | 2015-05-26 | 2015-05-28 | 214,605 | — | $0 | 214,605 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2012-01-06 | 2012-01-09 | 40,000 | — | $0 | 40,000 | SEC↗ |